Drug companies and universities are spending 55.6 million euros to develop a bank of stem cells to use in testing potential treatments for hard-to- treat diseases.
http://www.biospace.com/news_story.aspx?StoryID=281439&full=1
http://www.biospace.com/news_story.aspx?StoryID=281439&full=1
No comments:
Post a Comment